Skip to content

Kine TAB

Active
Private limited company·Activiteiten op het gebied van kinesitherapie· 5 yrs active
Groenendaallaan 103 ·2170 Antwerpen, Belgium
KBO/BCE: BE 0767.583.566
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Kine TAB is 0.2% (very low). The 2025 annual accounts show equity of €70k and a net result of €107k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 29% of 87 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-03-2026, 136 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 17-03-2026 136 d early 2026-00056027
31-12-2024 31-07-2025 08-07-2025 23 d early 2025-00244077
31-12-2023 31-07-2024 23-07-2024 8 d early 2024-00277650
31-12-2022 31-07-2023 10-09-2023 41 d late 2023-00445285

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€107k+33.3%
Working capital€-27k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 17-03-2026 with the NBB · fiscal year 2025 · verkort
€0€50k€100kOperating result 2022: €64k€64kNet result 2022: €48k€48kOperating result 2023: €65k€65kNet result 2023: €48k€48kOperating result 2024: €105k€105kNet result 2024: €81k€81kOperating result 2025: €119k€119kNet result 2025: €107k€107k2022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~43% of the level (threshold 35%). We therefore deliberately show no projection line.
€50k€100k€150k€200k2022: €54k2023: €102k2024: €183k2025: €70k2022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 22.6% 56.8%
better than 29% of 87 sector peers
Net result €107k €97k
better than 54% of 87 sector peers
Equity €70k €207k
better than 30% of 87 sector peers
Gross operating margin €151k €237k
better than 37% of 84 sector peers
Total assets €310k €591k
better than 35% of 87 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P29
2022: P33 · n=2602023: P45 · n=3452024: P54 · n=3822025: P29 · n=872022 2025
Stable position over 2022-2025 · n=87-382
Net result P54
2022: P47 · n=2562023: P45 · n=3392024: P53 · n=3722025: P54 · n=872022 2025
Stable position over 2022-2025 · n=87-372
Equity P30
2022: P35 · n=2602023: P48 · n=3452024: P58 · n=3822025: P30 · n=872022 2025
Improving position over 2022-2025 · n=87-382
Gross operating margin P37
2022: P33 · n=2532023: P39 · n=3342024: P42 · n=3722025: P37 · n=842022 2025
Stable position over 2022-2025 · n=84-372
Describes the position versus peers, not a forecast.
EBITDA
€149k
+17.7% 22-25
Net profit
€107k
+33.3% 22-25
Cash flow
€137k
+34.6% 22-25
Total assets
€310k
-5.5% 22-25
Equity
€70k
-61.7% 22-25
Working capital
€-27k
- 22-25
Income taxes
€26k
+16.7% 22-25
Dividends
€220k
- 22-25
Debt
€240k
+64.9% 22-25
Debt ≤ 1y
€208k
+113.4% 22-25
Debt > 1y
€32k
-33.8% 22-25
Current ratio
0.87
-55.3% 22-25
Quick ratio
0.87
-55.3% 22-25
Solvency
22.6%
-59.4% 22-25
Debt / equity
3.43
+330.0% 22-25
ROE
153.5%
+247.6% 22-25
ROA
34.6%
+41.0% 22-25
Interest coverage
46.97
+10.9% 22-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA€149k
Net profit€107k
Cash flow€137k
Staff costs-
Income taxes€26k
Dividends€220k
Total assets€310k
Equity€70k
Debt€240k
of which ≤ 1y€208k
of which > 1y€32k
Working capital€-27k
Employees (FTE)-
Ratios (computed)
2025
Current ratio0.87
Quick ratio0.87
Working capital ratio-8.9%
Solvency22.6%
Debt / equity3.43
Long-term debt ratio0.45
Interest coverage46.97
Gross margin-
Net margin-
ROA34.6%
ROE153.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€310k
Fixed assets 21/28€129k
Tangible fixed assets 22/27€75k
Financial fixed assets 28€54k
Current assets 29/58€181k
Amounts receivable within one year 40/41€3k
Investments 50/53€14k
Cash & bank 54/58€122k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€310k
Equity 10/15€70k
Contributions / capital 10/11€6k
Reserves 13€64k
Amounts payable 17/49€240k
Amounts payable after one year 17€32k
Amounts payable within one year 42/48€208k
Trade debts payable within one year 44€41k
Income statement
Gross operating margin 9900€151k
Operating result 9901€119k
Financial income 75€17k
Financial charges 65€3k
Result before taxes 9903€133k
Income taxes 67/77€26k
Net result for the period 9904€107k
Result to be appropriated 9905€107k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
53 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Directors

Directors & mandates

1 director
Former directors (1)
  • Vyncke
    Director
    State Gazette act 24109909 (19-07-2024)
    Former
    - → 31-12-2023
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Activiteiten op het gebied van kinesitherapie(86951)
Legal form Private limited company(610)
Incorporation28-04-2021
StatusActive
Postal code2170

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
13 companies at this address See who is registered here

Establishment units

1 location
Kine TAB
Groenendaallaan 103, 2170 AntwerpenSport- en recreatieonderwijs
since 20212.316.862.519
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area405 m²
Buildings1
Building footprint347 m²
Volume (LiDAR)4,705 m³
Tallest building16.9 m · ±4 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11422C0034/00C003 Flanders 405 m² 1 · 347 m² 16.9 m · 4 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

3 acts
All acts · 3 updated 2 months ago
2026
28-05-2026 General meeting · Officer appointment · Representation rule · Act object Open-capture extraction
  • Filing: 2026-05-19 · Kine TAB
  • Publication: 2026-05-28 · Kine TAB
  • General meeting: date: 2026-04-25, type: bijzondere algemene vergadering · Kine TAB
  • Officer appointment: date: 2026-04-25, role: bestuurder · Kine TAB
  • Representation rule: rule: bevoegdheidsbeperking aan de individuele vertegenwoordigingsmacht, statute_ref: artikel 12bis · Kine TAB
  • Act object: Benoeming bestuurder
  • Power of attorney: role: Gevolmachtigd fiscaal accountant · Kine TAB
Summary: General meeting · Officer appointment · Representation rule · Act object
2024
19-07-2024 Vyncke resigns as director Director changes
  • Vyncke, Bestuurder
Summary: v3.2
2021
30-04-2021 Incorporation of a new BV Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health53Profitability100Solvency29Growth78Stability94
71 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 53
Profitability 100
Solvency 29
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Ambulante revalidatieactiviteiten86905Activiteiten op het gebied van kinesitherapie86951Sport- en recreatieonderwijs85510Sport- en recreatieonderwijs85510Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
Legal nameNL Kine TAB
Registered office
Groenendaallaan 103 bus 3
2170 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.